SMW Biotech
StrategiesManufacturingStartupsDevelopmentInternationalConstruction



Understand Development and Manufacturing Mindsets
In developing a biotechnology product, one of the most difficult questions to answer is when to allocate resources for process development. Rapid process development can provide a key strategic advantage. Yet no one wants to allocate resources to a product that is not efficacious. Therefore, walking the fine line between too much too soon and too little too late is a fine balancing act.

Another issue that makes development difficult is the mindsets that occur in research, development and manufacturing. In some companies an outsider gets the impression these various groups have very different goals. In practice, the education and experience of these groups lead them to approach the same issues from divergent positions. When left to themselves these differences work against the success of the organization. However, there are ways to manage these differences. The first step is to recognize them.

The following table, from Wheelwright (1994), outlines some of the key differences in the manner of thinking between personnel in manufacturing operations and in R&D. Unless understood and treated, these differences may form insurmountable barriers to communication within the organization.


 ManufacturingR&D
GoalSeek product, even if underlying principles are not understoodSeek to understand principles, even if product goal is unmet
Means to achieve goalOur methods are betterDon't monkey with our invention
Project worthPursue only projects with high profitabilityPursue novel (and publishable) ideas
PlanningPlan and budget for given time; accept outcomePlan for outcome; accept whatever time is required
Capital versus labor implementationLabor is expensive, so replace it with capitalCapital is unavailable, so use more labor
Technical requirementsThey don't understand our situationThey're not real scientists
Endpoint definitionTransfer is not complete until values of all parameters are knownTransfer is complete when the process has been run once
Possibility of successThe process is underdeveloped and needs too many resourcesThey don't have the technical ability to handle our process
Wheelwright, S.M., "Commercializing Biotech Products," Bio/Technology 12:877:880 (1994).

Let SMW help you
Strategic Manufacturing Worldwide has particular expertise in developing manufacturing processes for biotech products and can help you address these technical issues.
  • process optimization for minimum cost and maximum yield
  • process throughput for maximum output
  • fermentation, cell culture and downstream process design
  • scaleup from development through production
    Contact SMW at info@smwbiotech.com.


    Copyright © 2004 Strategic Manufacturing Worldwide